MYC and breast carcinoma: Overexpression of c-Myc often correlates with late stage cancers, poor cellular differentiation, local and distant metastases, and poor prognosis in human malignancies, including breast cancer, hepatocellular carcinoma, gastric cancer, large B-cell lymphoma, and ovarian cancer [9–14].